The treatment was approved in 2024 for chronic graft-vs-host disease after failure of at least 2 prior lines of systemic therapy in patients weighing at least 40kg. The Food and Drug ...

SAN FRANCISCO — When Eli Lilly last year started offering lower-priced vials of its blockbuster obesity drug Zepbound, which were previously sold in injectable pens, it framed the move as a way ...

The vaccine is currently supplied in 2 vials: a single-dose vial of lyophilized varicella zoster virus glycoprotein E antigen component (powder) and a single-dose vial of adjuvant suspension ...